Cannabis Use Disorder and Residential Treatment: The Two-Week Withdrawal Window, Hyperemesis, and What to Tell Admissions

,
24/7 Confidential · Most Insurance Accepted · Joint Commission & CARF Accredited Programs · Nationwide Network
Two chairs in a living-room-style therapy space — EMDR trauma processing in residential addiction treatment

“It’s just weed” is one of the most common phrases on an admissions call, and it usually comes from someone who has already tried to stop on their own and could not get through the first week. In California, where adult-use cannabis has been legal for people 21 and older since 2016, it can feel strange to ask for residential treatment for something sold in a storefront. Legal status does not change the diagnosis, though, and it does not change what the first two weeks off a daily habit feel like.

This guide covers how cannabis use disorder is assessed, what withdrawal actually involves, why cannabinoid hyperemesis syndrome matters for planning, and the specific details admissions needs from you so the first days of residential treatment are built around your real pattern of use.

Cannabis Withdrawal in Residential Treatment: The Short Answer

Cannabis withdrawal is real and it is usually not medically dangerous on its own, but it is uncomfortable enough to drive relapse. According to the National Institute on Drug Abuse, cannabis withdrawal symptoms such as irritability, poor sleep, low appetite, restlessness, and cravings typically peak within the first week after stopping and can last up to two weeks. There is currently no FDA-approved medication for cannabis use disorder, so residential care for cannabis focuses on managing sleep, appetite, anxiety, and cravings through those first 14 days while therapy addresses why use became daily. The planning changes significantly if alcohol or benzodiazepines are also being used, because withdrawal from those substances can cause seizures and requires medical supervision.

How Cannabis Use Disorder Is Diagnosed

Clinicians use the DSM-5 criteria for cannabis use disorder, the same 11-criterion framework used for other substances. It includes items such as using more than intended, unsuccessful attempts to cut down, cravings, giving up activities, continued use despite problems, tolerance, and withdrawal. Two or three criteria within a 12-month period indicate a mild disorder, four or five moderate, and six or more severe.

Residential care is generally considered when the disorder is moderate to severe and outpatient attempts have not held, when there is a co-occurring mental health condition, or when home is not a place where stopping is realistic. That level-of-care decision follows the ASAM Criteria from the American Society of Addiction Medicine, not the substance alone.

Why the First Week Is Harder Than People Expect

Most people who call us are surprised by how much the first several days hurt. The mechanisms are fairly consistent:

  • Sleep rebound: Many daily users rely on cannabis to fall asleep, and stopping often brings insomnia and vivid, intense dreams for several nights.
  • Appetite loss: Low appetite and nausea are common early, which matters more for someone who has also had vomiting episodes.
  • Irritability and anxiety: Mood is often at its worst in the first days, and this is when people most often talk themselves into leaving.
  • Concentrate tolerance: People using high-potency vape cartridges or dabs throughout the day tend to describe a rougher withdrawal than people smoking flower occasionally, which is why potency and route are asked about at intake.
  • Conditioned cues: When cannabis has been part of every evening, every drive, or every social plan, cravings are tied to routine as much as to chemistry.

None of this is a reason to avoid treatment. It is the reason a structured setting helps: the hardest days happen where staff can adjust sleep routines, nutrition, and support in real time.

Cannabinoid Hyperemesis Syndrome: The Detail That Changes the Plan

Cannabinoid hyperemesis syndrome (CHS) is a pattern of repeated, severe vomiting episodes in some people with long-term, heavy cannabis use. A recognizable sign is relief from hot showers or baths, sometimes taken many times a day. Episodes can lead to dehydration and emergency department visits. The Centers for Disease Control and Prevention and NIDA both describe vomiting syndromes among the health effects of frequent use.

Receive Guidance, Call Now

Stopping cannabis is generally the only lasting treatment for CHS, and symptoms can take time to settle after use ends. If you have had vomiting episodes, ER visits for vomiting, or a habit of long hot showers to feel better, tell admissions. It affects hydration monitoring, whether medical clearance is needed before arrival, and how the first days are staffed.

When Medical Supervision Is Required

Cannabis alone rarely requires medical detox. Combined use is a different matter. If you are also drinking daily or taking benzodiazepines such as alprazolam, clonazepam, or lorazepam, whether prescribed or not, withdrawal from those substances carries a risk of seizures and must be medically supervised. Do not stop alcohol or benzodiazepines abruptly on your own before admission. Tell admissions exactly what you take and how much, and let the clinical team decide whether detox comes first.

Heavy cannabis use, especially high-potency products, can also be associated with psychotic symptoms in some people, according to NIDA’s research report on cannabis. Paranoia, hearing things others do not, or a past psychotic episode should be shared up front so a psychiatric assessment can be arranged. If you or someone you love is in crisis right now, call or text 988, or call 911.

What to Tell Admissions: A Checklist You Can Use Today

Before you call, write down answers to these questions. It takes about ten minutes and makes the assessment more accurate:

  1. Product and route: Flower, vape cartridges, dabs or other concentrates, edibles, or a mix.
  2. Frequency and timing: How many times a day, whether you use on waking, and the date and time of last use.
  3. Other substances: Alcohol, benzodiazepines, sleep medications, stimulants, opioids, or nicotine, with amounts. This is the most important item on the list for safety.
  4. Vomiting history: Any repeated vomiting episodes, ER visits, or relief from hot showers.
  5. Mental health history: Anxiety, depression, panic, paranoia, or any past psychotic symptoms, plus current prescriptions.
  6. Previous attempts to stop: How long you lasted and what made you start again. That answer often shapes the treatment plan more than anything else.
  7. Medical cannabis recommendation: If you have one, say so and name the condition it was for, so the team can plan how that condition will be managed.

Our admissions team can walk through these with you by phone at (877) 328-1968.

What to Ask Admissions

  • How is insomnia handled during the first two weeks, and which sleep medications are and are not used?
  • Is a medical evaluation done on arrival if I have had vomiting episodes or combined alcohol or benzodiazepine use?
  • What therapy approaches are used for cannabis use disorder specifically?
  • Will I see a psychiatric provider if anxiety or mood symptoms are part of the picture?
  • What is my insurance likely to cover? You can start that process through our insurance verification page.

A Note From the Admissions Side

The pattern we see most often is not someone in physical danger from cannabis. It is someone who has stopped many times, made it three or four days, and restarted when sleep fell apart or anxiety spiked. Often there is a second substance in the background, usually alcohol, that nobody mentioned on the first call because the conversation was framed around cannabis. Those are the two facts worth bringing to the phone: how far into withdrawal you have gotten before, and everything else you are taking. They shape the plan more than the amount of cannabis does.

If you are weighing residential care for yourself or a family member, call (877) 328-1968 to talk through the level-of-care questions. You can also contact the free, confidential SAMHSA National Helpline at 1-800-662-4357 for referrals at any time.

This article was written by Jonathan Beazley, CADC-CAS, M-RAS, CCMI-i. It is for educational purposes only and is not medical advice, diagnosis, or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and must be medically supervised. Always consult a qualified healthcare provider about your specific situation. If you are in crisis, call or text 988 or call 911.